Loading…

Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region

Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and exa...

Full description

Saved in:
Bibliographic Details
Published in:AIDS and behavior 2024-11, Vol.28 (11), p.3629-3642
Main Authors: Bailey, Katie, Abramovitz, Daniela, Rangel, Gudelia, Harvey-Vera, Alicia, Vera, Carlos F., Patterson, Thomas L., Sánchez-Lira, Jaime Arredondo, Davidson, Peter J., Garfein, Richard S., Smith, Laramie R., Pitpitan, Eileen V., Goldenberg, Shira M., Strathdee, Steffanie A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3
container_end_page 3642
container_issue 11
container_start_page 3629
container_title AIDS and behavior
container_volume 28
creator Bailey, Katie
Abramovitz, Daniela
Rangel, Gudelia
Harvey-Vera, Alicia
Vera, Carlos F.
Patterson, Thomas L.
Sánchez-Lira, Jaime Arredondo
Davidson, Peter J.
Garfein, Richard S.
Smith, Laramie R.
Pitpitan, Eileen V.
Goldenberg, Shira M.
Strathdee, Steffanie A.
description Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.
doi_str_mv 10.1007/s10461-024-04433-9
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3085116144</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3085116144</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3</originalsourceid><addsrcrecordid>eNp9kUuOEzEQhi0EYobABVggS2zYNJTbj-5ehsxAIo0EIsOwtDx-dBx17GB3g7LjCogbchIMCSCxYOWS_NVfpfoQekzgOQFoXmQCTJAKalYBY5RW3R10TnhDK1pzdrfU0EHVEMHP0IOctwDQiaa7j85oBwJa2pyjr2vlLF6FrdWjjwGv7eCqS-e8VvqAfcbznKP2arQGf_bjBi8XN1gFg5ermwKnuI_Zj_6THw94vouhx29t3A8Wf9jEUyy-SFOfsQ943Fi8VgFfeNvH71--XfvtpILCL2MyNuF3ti8rPET3nBqyfXR6Z-j9q8vrxbK6evN6tZhfVbrmYqycNkTcEt5SUzMnXAOUOKCdalxratIowxyzjLq6c8Zxwh3XQteECsGIAENn6Nkxd5_ix8nmUe581nYYVLBxypJCywkRpFx2hp7-g27jlELZTtKCgKC8awtVHymdYs7JOrlPfqfSQRKQP4XJozBZhMlfwmRXmp6coqfbnTV_Wn4bKgA9Arl8hd6mv7P_E_sDk_agyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3116063598</pqid></control><display><type>article</type><title>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</title><source>Springer Nature</source><source>Sociological Abstracts</source><creator>Bailey, Katie ; Abramovitz, Daniela ; Rangel, Gudelia ; Harvey-Vera, Alicia ; Vera, Carlos F. ; Patterson, Thomas L. ; Sánchez-Lira, Jaime Arredondo ; Davidson, Peter J. ; Garfein, Richard S. ; Smith, Laramie R. ; Pitpitan, Eileen V. ; Goldenberg, Shira M. ; Strathdee, Steffanie A.</creator><creatorcontrib>Bailey, Katie ; Abramovitz, Daniela ; Rangel, Gudelia ; Harvey-Vera, Alicia ; Vera, Carlos F. ; Patterson, Thomas L. ; Sánchez-Lira, Jaime Arredondo ; Davidson, Peter J. ; Garfein, Richard S. ; Smith, Laramie R. ; Pitpitan, Eileen V. ; Goldenberg, Shira M. ; Strathdee, Steffanie A.</creatorcontrib><description>Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.</description><identifier>ISSN: 1090-7165</identifier><identifier>ISSN: 1573-3254</identifier><identifier>EISSN: 1573-3254</identifier><identifier>DOI: 10.1007/s10461-024-04433-9</identifier><identifier>PMID: 39060837</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; California - epidemiology ; Coinjection ; Correlation ; Disease transmission ; Drugs ; Effectiveness ; Female ; Fentanyl ; Health Psychology ; Hepatitis C - epidemiology ; HIV ; HIV Infections - epidemiology ; HIV Seropositivity - epidemiology ; Homeless people ; Homelessness ; Human immunodeficiency virus ; Humans ; Inequality ; Infectious Diseases ; Injection ; Longitudinal Studies ; Male ; Measures ; Medicine ; Medicine &amp; Public Health ; Mexico - epidemiology ; Middle Aged ; Original Paper ; Public Health ; Residents ; Risk ; Risk behavior ; Risk taking ; Self Efficacy ; Substance Abuse, Intravenous - complications ; Substance Abuse, Intravenous - epidemiology ; Substance Abuse, Intravenous - psychology</subject><ispartof>AIDS and behavior, 2024-11, Vol.28 (11), p.3629-3642</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3</cites><orcidid>0000-0002-7724-691X ; 0000-0003-4231-211X ; 0000-0002-4794-117X ; 0009-0001-2764-5533 ; 0000-0003-0159-0981 ; 0000-0002-8708-8169 ; 0000-0003-3663-7153 ; 0000-0003-3376-152X ; 0000-0003-1633-9749 ; 0000-0002-5371-3229 ; 0000-0002-2969-7193</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,33774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39060837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bailey, Katie</creatorcontrib><creatorcontrib>Abramovitz, Daniela</creatorcontrib><creatorcontrib>Rangel, Gudelia</creatorcontrib><creatorcontrib>Harvey-Vera, Alicia</creatorcontrib><creatorcontrib>Vera, Carlos F.</creatorcontrib><creatorcontrib>Patterson, Thomas L.</creatorcontrib><creatorcontrib>Sánchez-Lira, Jaime Arredondo</creatorcontrib><creatorcontrib>Davidson, Peter J.</creatorcontrib><creatorcontrib>Garfein, Richard S.</creatorcontrib><creatorcontrib>Smith, Laramie R.</creatorcontrib><creatorcontrib>Pitpitan, Eileen V.</creatorcontrib><creatorcontrib>Goldenberg, Shira M.</creatorcontrib><creatorcontrib>Strathdee, Steffanie A.</creatorcontrib><title>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</title><title>AIDS and behavior</title><addtitle>AIDS Behav</addtitle><addtitle>AIDS Behav</addtitle><description>Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.</description><subject>Adult</subject><subject>California - epidemiology</subject><subject>Coinjection</subject><subject>Correlation</subject><subject>Disease transmission</subject><subject>Drugs</subject><subject>Effectiveness</subject><subject>Female</subject><subject>Fentanyl</subject><subject>Health Psychology</subject><subject>Hepatitis C - epidemiology</subject><subject>HIV</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Seropositivity - epidemiology</subject><subject>Homeless people</subject><subject>Homelessness</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Inequality</subject><subject>Infectious Diseases</subject><subject>Injection</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Measures</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mexico - epidemiology</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Public Health</subject><subject>Residents</subject><subject>Risk</subject><subject>Risk behavior</subject><subject>Risk taking</subject><subject>Self Efficacy</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Substance Abuse, Intravenous - epidemiology</subject><subject>Substance Abuse, Intravenous - psychology</subject><issn>1090-7165</issn><issn>1573-3254</issn><issn>1573-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>BHHNA</sourceid><recordid>eNp9kUuOEzEQhi0EYobABVggS2zYNJTbj-5ehsxAIo0EIsOwtDx-dBx17GB3g7LjCogbchIMCSCxYOWS_NVfpfoQekzgOQFoXmQCTJAKalYBY5RW3R10TnhDK1pzdrfU0EHVEMHP0IOctwDQiaa7j85oBwJa2pyjr2vlLF6FrdWjjwGv7eCqS-e8VvqAfcbznKP2arQGf_bjBi8XN1gFg5ermwKnuI_Zj_6THw94vouhx29t3A8Wf9jEUyy-SFOfsQ943Fi8VgFfeNvH71--XfvtpILCL2MyNuF3ti8rPET3nBqyfXR6Z-j9q8vrxbK6evN6tZhfVbrmYqycNkTcEt5SUzMnXAOUOKCdalxratIowxyzjLq6c8Zxwh3XQteECsGIAENn6Nkxd5_ix8nmUe581nYYVLBxypJCywkRpFx2hp7-g27jlELZTtKCgKC8awtVHymdYs7JOrlPfqfSQRKQP4XJozBZhMlfwmRXmp6coqfbnTV_Wn4bKgA9Arl8hd6mv7P_E_sDk_agyQ</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Bailey, Katie</creator><creator>Abramovitz, Daniela</creator><creator>Rangel, Gudelia</creator><creator>Harvey-Vera, Alicia</creator><creator>Vera, Carlos F.</creator><creator>Patterson, Thomas L.</creator><creator>Sánchez-Lira, Jaime Arredondo</creator><creator>Davidson, Peter J.</creator><creator>Garfein, Richard S.</creator><creator>Smith, Laramie R.</creator><creator>Pitpitan, Eileen V.</creator><creator>Goldenberg, Shira M.</creator><creator>Strathdee, Steffanie A.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U3</scope><scope>7U9</scope><scope>BHHNA</scope><scope>C1K</scope><scope>H94</scope><scope>K7.</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7724-691X</orcidid><orcidid>https://orcid.org/0000-0003-4231-211X</orcidid><orcidid>https://orcid.org/0000-0002-4794-117X</orcidid><orcidid>https://orcid.org/0009-0001-2764-5533</orcidid><orcidid>https://orcid.org/0000-0003-0159-0981</orcidid><orcidid>https://orcid.org/0000-0002-8708-8169</orcidid><orcidid>https://orcid.org/0000-0003-3663-7153</orcidid><orcidid>https://orcid.org/0000-0003-3376-152X</orcidid><orcidid>https://orcid.org/0000-0003-1633-9749</orcidid><orcidid>https://orcid.org/0000-0002-5371-3229</orcidid><orcidid>https://orcid.org/0000-0002-2969-7193</orcidid></search><sort><creationdate>20241101</creationdate><title>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</title><author>Bailey, Katie ; Abramovitz, Daniela ; Rangel, Gudelia ; Harvey-Vera, Alicia ; Vera, Carlos F. ; Patterson, Thomas L. ; Sánchez-Lira, Jaime Arredondo ; Davidson, Peter J. ; Garfein, Richard S. ; Smith, Laramie R. ; Pitpitan, Eileen V. ; Goldenberg, Shira M. ; Strathdee, Steffanie A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>California - epidemiology</topic><topic>Coinjection</topic><topic>Correlation</topic><topic>Disease transmission</topic><topic>Drugs</topic><topic>Effectiveness</topic><topic>Female</topic><topic>Fentanyl</topic><topic>Health Psychology</topic><topic>Hepatitis C - epidemiology</topic><topic>HIV</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Seropositivity - epidemiology</topic><topic>Homeless people</topic><topic>Homelessness</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Inequality</topic><topic>Infectious Diseases</topic><topic>Injection</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Measures</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mexico - epidemiology</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Public Health</topic><topic>Residents</topic><topic>Risk</topic><topic>Risk behavior</topic><topic>Risk taking</topic><topic>Self Efficacy</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Substance Abuse, Intravenous - epidemiology</topic><topic>Substance Abuse, Intravenous - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bailey, Katie</creatorcontrib><creatorcontrib>Abramovitz, Daniela</creatorcontrib><creatorcontrib>Rangel, Gudelia</creatorcontrib><creatorcontrib>Harvey-Vera, Alicia</creatorcontrib><creatorcontrib>Vera, Carlos F.</creatorcontrib><creatorcontrib>Patterson, Thomas L.</creatorcontrib><creatorcontrib>Sánchez-Lira, Jaime Arredondo</creatorcontrib><creatorcontrib>Davidson, Peter J.</creatorcontrib><creatorcontrib>Garfein, Richard S.</creatorcontrib><creatorcontrib>Smith, Laramie R.</creatorcontrib><creatorcontrib>Pitpitan, Eileen V.</creatorcontrib><creatorcontrib>Goldenberg, Shira M.</creatorcontrib><creatorcontrib>Strathdee, Steffanie A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Social Services Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Sociological Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>AIDS and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bailey, Katie</au><au>Abramovitz, Daniela</au><au>Rangel, Gudelia</au><au>Harvey-Vera, Alicia</au><au>Vera, Carlos F.</au><au>Patterson, Thomas L.</au><au>Sánchez-Lira, Jaime Arredondo</au><au>Davidson, Peter J.</au><au>Garfein, Richard S.</au><au>Smith, Laramie R.</au><au>Pitpitan, Eileen V.</au><au>Goldenberg, Shira M.</au><au>Strathdee, Steffanie A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region</atitle><jtitle>AIDS and behavior</jtitle><stitle>AIDS Behav</stitle><addtitle>AIDS Behav</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>28</volume><issue>11</issue><spage>3629</spage><epage>3642</epage><pages>3629-3642</pages><issn>1090-7165</issn><issn>1573-3254</issn><eissn>1573-3254</eissn><abstract>Safe injection self-efficacy (SISE) is negatively associated with injection risk behaviors among people who inject drugs (PWID) but has not been examined in differing risk environments. We compared responses to a validated SISE scale between PWID in San Diego, California and Tijuana, Mexico, and examine correlates of SISE among PWID in Tijuana. PWID were recruited via street outreach for a longitudinal cohort study from October 2020–September 2021. We compared SISE scale items by city. Due to low variability in SISE scores among San Diego residents, we restricted analysis of factors associated with SISE to Tijuana residents and identified correlates of SISE score levels (low, medium, high) using ordinal logistic regression. Of 474 participants, most were male (74%), Latinx (78%) and Tijuana residents (73%). Mean age was 44. Mean SISE scores among San Diego residents were high (3.46 of 4 maximum) relative to Tijuana residents (mean: 1.93). Among Tijuana residents, White race and having previously resided in San Diego were associated with higher SISE scores. HCV and HIV seropositivity, homelessness, fentanyl use, polysubstance co-injection, and greater injection frequency were associated with lower SISE scores. We found profound inequalities between Tijuana and San Diego SISE, likely attributable to differential risk environments. Associations with fentanyl and polysubstance co-injection, injection frequency, and both HIV and HCV seropositivity suggest that SISE contribute to blood-borne infection transmission risks in Tijuana. SISE reflects an actionable intervention target to reduce injection risk behaviors, but structural interventions are required to change the risk environment.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>39060837</pmid><doi>10.1007/s10461-024-04433-9</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-7724-691X</orcidid><orcidid>https://orcid.org/0000-0003-4231-211X</orcidid><orcidid>https://orcid.org/0000-0002-4794-117X</orcidid><orcidid>https://orcid.org/0009-0001-2764-5533</orcidid><orcidid>https://orcid.org/0000-0003-0159-0981</orcidid><orcidid>https://orcid.org/0000-0002-8708-8169</orcidid><orcidid>https://orcid.org/0000-0003-3663-7153</orcidid><orcidid>https://orcid.org/0000-0003-3376-152X</orcidid><orcidid>https://orcid.org/0000-0003-1633-9749</orcidid><orcidid>https://orcid.org/0000-0002-5371-3229</orcidid><orcidid>https://orcid.org/0000-0002-2969-7193</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1090-7165
ispartof AIDS and behavior, 2024-11, Vol.28 (11), p.3629-3642
issn 1090-7165
1573-3254
1573-3254
language eng
recordid cdi_proquest_miscellaneous_3085116144
source Springer Nature; Sociological Abstracts
subjects Adult
California - epidemiology
Coinjection
Correlation
Disease transmission
Drugs
Effectiveness
Female
Fentanyl
Health Psychology
Hepatitis C - epidemiology
HIV
HIV Infections - epidemiology
HIV Seropositivity - epidemiology
Homeless people
Homelessness
Human immunodeficiency virus
Humans
Inequality
Infectious Diseases
Injection
Longitudinal Studies
Male
Measures
Medicine
Medicine & Public Health
Mexico - epidemiology
Middle Aged
Original Paper
Public Health
Residents
Risk
Risk behavior
Risk taking
Self Efficacy
Substance Abuse, Intravenous - complications
Substance Abuse, Intravenous - epidemiology
Substance Abuse, Intravenous - psychology
title Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego–Tijuana Border Region
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A09%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safe%20Injection%20Self-Efficacy%20is%20Associated%20with%20HCV%20and%20HIV%20Seropositivity%20Among%20People%20Who%20Inject%20Drugs%20in%20the%20San%20Diego%E2%80%93Tijuana%20Border%20Region&rft.jtitle=AIDS%20and%20behavior&rft.au=Bailey,%20Katie&rft.date=2024-11-01&rft.volume=28&rft.issue=11&rft.spage=3629&rft.epage=3642&rft.pages=3629-3642&rft.issn=1090-7165&rft.eissn=1573-3254&rft_id=info:doi/10.1007/s10461-024-04433-9&rft_dat=%3Cproquest_cross%3E3085116144%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c256t-fcd16b1583d24f6f7031f039a7f8d217ad4f4e43f29fdf515f5c6c213664160d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3116063598&rft_id=info:pmid/39060837&rfr_iscdi=true